ライフサイエンスコーパス: kappa

1 be 0.44 (95% confidence = 0.16-0.68, Fleiss' kappa).

2 e authors' scores was analyzed using Cohen's Kappa.

3 observer agreement was assessed using Fleiss kappa.

4 n-situ tuned from near-zero to near-infinity kappa.

5 y with continuously changing and anisotropic kappa.

6 of visualization was assessed with weighted kappa.

7 the agreement with histology using weighted Kappa.

8 expert urological pathologists using Cohen's kappa.

9 rom 60 to 86% among attendings and trainees (kappa 0.43 to 0.86).

10 bstantial agreement (linear-weighted Cohen's kappa 0.62).

11 were highly concordant at the pharynx (95%, kappa 0.85), rectum (99%, kappa 0.97), urethra/urine (83

12 reement with the reference standard (Cohen's kappa 0.868) and sensitivity/specificity to detect DR we

13 R and targeted sequencing was 96-99% (n=800, kappa 0.89-0.93).

14 19 diagnosis between all methods was 95.88% (Kappa 0.901).

15 the pharynx (95%, kappa 0.85), rectum (99%, kappa 0.97), urethra/urine (83%, kappa=0.87) and endocer

16 cases and yielded considerable disagreement (kappa = 0.177).

17 reement between the two phenotypes was poor: kappa = 0.213 +/- 0.006.

18 liability of Alpha/Beta classification (mean kappa = 0.31).

19 ment among pathologists ranges between fair (kappa = 0.35 +/- 0.13 SEM and kappa = 0.38 +/- 0.11 SEM)

20 between fair (kappa = 0.35 +/- 0.13 SEM and kappa = 0.38 +/- 0.11 SEM) and moderate (kappa = 0.52 +/

21 face slabs was moderate for the "ORCC" slab (kappa = 0.43; range, 0.41-0.60) and substantial for the

22 d (kappa = 0.78-1) than reference 3D LA LGE (kappa = 0.44-0.75).

23 automated grading shows moderate agreement (kappa = 0.48 +/- 0.14 SEM) with the consensus reading.

24 and kappa = 0.38 +/- 0.11 SEM) and moderate (kappa = 0.52 +/- 0.13 SEM).

25 .58) or provider-collected cervical samples (kappa = 0.54) was moderate.

26 s and self-collected cervicovaginal samples (kappa = 0.58) or provider-collected cervical samples (ka

27 iagnoses were overall less accurately coded (kappa = 0.61, 0.48, and 0.52 for vitreous hemorrhage, re

28 kappa = 0.67) and T2-weighted heterogeneity (kappa = 0.62).

29 for stage of DR and the documented standard (kappa = 0.66).

30 ts was substantial for T2-weighted SI (Cohen kappa = 0.67) and T2-weighted heterogeneity (kappa = 0.6

31 reement with the human expert (R (2) = 0.78, kappa = 0.67).

32 1-0.60) and substantial for the custom slab (kappa = 0.67; range, 0.61-0.80).

33 reement was found in those aged 51-65 years (kappa = 0.68).

34 both intra- (kappa = 0.72) and interreader (kappa = 0.70) reproducibility.

35 isibility for MUSE DWI over single-shot DWI (kappa = 0.70).Conclusion: MUSE DWI is a promising high-s

36 the interreader agreement for TRA category (kappa = 0.71; 95% CI: 0.59, 0.84; P < .01).

37 gested substantial agreement in both intra- (kappa = 0.72) and interreader (kappa = 0.70) reproducibi

38 ured and reported antibiotic use was modest (kappa = 0.72).

39 > 0.85) and substantial agreement for Y181C (kappa = 0.720).

40 Interrater agreement was substantial (kappa = 0.74; 95% CI: 0.70, 0.77).

41 stantial by Landis and Koch criteria (Fleiss kappa = 0.77).

42 f 92% (Cohen's kappa, kappa = 0.89) and 86% (kappa = 0.78) in the ex vivo grading of steatosis and fi

43 n visual scores was higher for the proposed (kappa = 0.78-1) than reference 3D LA LGE (kappa = 0.44-0

44 There was substantial agreement (kappa = 0.81) between C.D. and K.P.L. in independently a

45 encoding led to an overall accuracy of 87% (kappa = 0.81) for the grading of steatosis.

46 The inter-rater reliability was excellent (kappa = 0.815, P < 0.001, 95% confidence interval [0.605

47 d diagnosis and histopathological diagnosis (kappa = 0.818).

48 ct on a patient level (3-category unweighted kappa = 0.83 +/- 0.05, linear weighted kappa = 0.90 +/-

49 g site and in the aggregate dataset (Cohen's Kappa = 0.83, 95% CI = 0.829-0.831).

50 ayed excellent concordance with the control (kappa = 0.85 to 0.89).

51 s pathologists for hHSIL vs less than hHSIL (kappa = 0.86 [95% CI, .79-.93]).

52 ders for all vitreoretinal findings was 91% (kappa = 0.86; 95% confidence interval, 0.82-0.90; P < 0.

53 Interreader agreement was almost perfect (kappa = 0.87; 95% CI: 0.80, 0.93).

54 d steatosis with an overall accuracy of 93% (kappa = 0.88).

55 ed overall accuracies of 92% (Cohen's kappa, kappa = 0.89) and 86% (kappa = 0.78) in the ex vivo grad

56 ghted kappa = 0.83 +/- 0.05, linear weighted kappa = 0.90 +/- 0.06, and dichotomous kappa = 0.91 +/-

57 ghted kappa = 0.90 +/- 0.06, and dichotomous kappa = 0.91 +/- 0.07).

58 tween the two platforms as "almost perfect" (kappa = 0.922; standard error, 0.051).

59 nce interval: 0.97, 0.99) and interobserver (kappa = 0.93; 95% confidence interval: 0.90, 0.95) agree

60 e inter-rater agreement for PHOMS was 97.9% (kappa = 0.951).

61 er agreement of image quality was excellent (kappa = 0.96).

62 Intraobserver (kappa = 0.98; 95% confidence interval: 0.97, 0.99) and i

63 etecting abnormalities on chest radiographs (kappa = 0.99; 95% confidence interval: 0.97, 1.00) and C

64 95% confidence interval: 0.97, 1.00) and CT (kappa = 0.99; 95% confidence interval: 0.98, 1.00).

65 We extract a critical exponent kappa ~ 0.38 +/- 0.02 in agreement with recent high-prec

66 e that should manifest via a residual value (kappa(0)/T) in the zero-temperature limit.

67 reement between whole-body MRI and CT (Cohen kappa, 0.15).

68 agreement for technologists was fair (Fleiss kappa, 0.36 [95% CI: 0.29, 0.43]), while that for radiol

69 us beading, agreement was moderate (weighted kappa, 0.41 to 0.60).

70 e that for radiologists was moderate (Fleiss kappa, 0.59 [95% CI: 0.52, 0.66]).

71 e was moderate both for the four categories (kappa=0.43) and for the dichotomous classification (kapp

72 .43) and for the dichotomous classification (kappa=0.51).

73 .84) and for the dichotomous classification (kappa=0.63 to 0.84).

74 nearly perfect for the analysis by category (kappa=0.64 to 0.84) and for the dichotomous classificati

75 ectum (99%, kappa 0.97), urethra/urine (83%, kappa=0.87) and endocervix/vagina (100%, kappa 1.0) (p<0

76 wed consistency but with variability (kappa [kappa]=0.79).

77 3%, kappa=0.87) and endocervix/vagina (100%, kappa 1.0) (p<0.005 for all comparisons).

78 lues of 1.78 and 1.16 (close to that of air, kappa = 1) at operation frequencies of 100 kilohertz and

79 Six complexes of formula [Ir(eta(5):kappa(1)-C(5)Me(4)CH(2)py)(C,N)]PF(6), where C(5)Me(4)CH

80 the metal center, resulting in an Ir(eta(5):kappa(1)-C(5)Me(4)CH(2)pyN) tether-ring structure, as co

81 70 ng/mmol or >370 ng/mmol perfectly agreed (kappa=1.0) with a histologic activity index <=1 or >1 in

82 s best described by the orientation factors <kappa(2)> = 0.17 +/- 0.16 and <|kappa|> = 0.35 +/- 0.20,

83 e, (eta(2)-PhC=CPh)Ni((i)Pr(2)PCH(2)NPh)(2)M(kappa(2)-(i)Pr(2)PCH(2)NPh).

84 on, and physical characterization of Cp(2)Ti(kappa(2)-(t)BuNCN(t)Bu) (3) (Cp = cyclopentadienyl, (t)B

85 the sigma-complexes IrH(3)(eta(2)-H-SiR(3)){kappa(2)-cis-P,P-[xant(P(i)Pr(2))(2)]}, which evolve to

86 cumulenes to metal centers, the monometallic kappa(2)-ECE (E = O, S, NR) coordination mode has not be

87 he nitritocopper(II) cryptate complex [mC]Cu(kappa(2)-O(2)N)(ClO(4)) (1a), this report illustrates NO

88 ed in the outer coordination sphere, [mCH]Cu(kappa(2)-O(2)N)(ClO(4))(2) (3), also reacts with substit

89 ))(3)}(H(2)Bpin) and =SiO-La{C(SiHMe(2))(3)}{kappa(2)-pinB-O(CMe(2))(2)OBH(3)} are identified by deta

90 complex, [((Me(3)Si)(2)N)(2)(THF)U(mu-NH)(mu-kappa(2):C,N-CH(2)SiMe(2)NSiMe(3))U(N(SiMe(3))(2)))(THF)

91 ex [Na(DME)(3)][((Me(3)Si)(2)N)(2)U(mu-N)(mu-kappa(2):CN-CH(2)SiMe(2)NSiMe(3))U(N(SiMe(3))(2))(2)] (D

92 The saturated trihydride IrH(3){kappa(3)-P,O,P-[xant(P(i)Pr(2))(2)]} (1; xant(P(i)Pr(2))

93 e dihydride-silyl derivatives IrH(2)(SiR(3)){kappa(3)-P,O,P-[xant(P(i)Pr(2))(2)]} (SiR(3) = SiEt(3) (

94 hodium(I)-monohydride catalyst precursor RhH{kappa(3)-P,O,P-[xant(P(i)Pr(2))(2)]} (xant(P(i)Pr(2))(2)

95 ted both the efficacy and potency of partial kappa agonists, such as the benzomorphans, and the class

96 ncordant with the guideline recommendations (kappa agreement 0.88, 95% CI 0.64-1.00).

97 Light kappa agreement between readers for LI-RADS categorizati

98 The Kappa agreement coefficient between two methods was - 0.

99 QGIT and TST kappa agreement coefficients were 0.4 and 0.5, respectiv

100 of a forty-three-year-old male patient with kappa AL amyloidosis.

101 A kidney biopsy confirmed the diagnosis of kappa AL amyloidosis.

102 Cohen's kappa analysis rated the strength of agreement between t

103 sion is focused on keratinocyte-specific IFN-kappa and is mediated through E5-induced changes in grow

104 Cohen (two-reader) and Fleiss (three-reader) kappa and the bootstrap method were used to analyze inte

105 Materials with high thermal conductivity (kappa) are of technological importance and fundamental i

106 Nuclear factor kappa B (NF-kappaB) activation in the liver of SCD mice

107 echnologies demonstrated that nuclear factor kappa B (NF-kappaB) and cholesterol biosynthesis pathway

108 concentrations that activated nuclear factor-kappa B (NF-kappaB) in LUHMES cells, EMA and ICM induced

109 The nuclear factor kappa B (NF-kappaB) signaling system, a key regulator of

110 in vivo model to investigate nuclear factor kappa B (NF-kappaB) signaling, a critical regulator of i

111 rminal kinases (JNK), EKR1/2, nuclear factor-kappa B (NF-kappaB)) in the gastrocnemius (G).

112 that are primarily driven by nuclear factor kappa B (NF-kappaB), interferon regulatory factor (IRF),

113 ted protein (MAP) kinases and nuclear factor kappa B and decreased myogenic differentiation, as refle

114 loss of critical members of the inhibitor of kappa B kinase (IKK) complex, NF-kappaB essential modifi

115 onstrate that HDAC9 binds to IKK (inhibitory kappa B kinase)-alpha and beta, resulting in their deace

116 Serum receptor activator of nuclear factor kappa B ligand (RANKL) and its antagonist osteoprotegeri

117 ures to receptor activator of nuclear factor kappa B ligand (RANKL), macrophage colony-stimulating fa

118 lpha]), as well as NF-kappaB (nuclear factor kappa B) and inflammasome activation.

119 ted with increased NF-kappaB (nuclear factor kappa B) binding activity and expression of inflammatory

120 kinases as well as NFkappaB (nuclear factor kappa B).

121 or, which in turn activates a nuclear factor kappa B-dependent metabolic pathway, leading to aerobic

122 an increase in inhibitors of nuclear factor kappa-B (NF-kappaB) signaling, possibly inappropriately

123 occupancy of KDM7A and UTX at nuclear factor kappa-B (NF-kappaB)-associated elements in human ECs.

124 ays for Wnt signaling or nuclear factor (NF)-kappa-B activity.

125 d gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differentiation-associate

126 ease in receptor activator of unclear factor kappa-B ligand, periostin, and peroxidasin gene expressi

127 ), high-mobility group box 1, nuclear factor kappa beta, myeloid differentiation primary response 88,

128 Using receptor activator of nuclear factor kappa-Beta ligand (RANKL) induced osteoclastogenesis to

129 sion of receptor-activator of nuclear factor kappa-Beta ligand (Rankl) leads to ectopic formation of

130 Cohen weighted kappa between the committee and model was 0.86, comparab

131 ethyl cellulose (CMC) and kappa-carrageenan (kappa-C) (0-0.3%) on the height and textural parameters

132 6 cm when using 26.8% X, 50.5% CMC and 22.7% kappa-C.

133 nthan (X), carboxymethyl cellulose (CMC) and kappa-carrageenan (kappa-C) (0-0.3%) on the height and t

134 drolytic activity on kappa-caseins, cleaving kappa-casein at four main sites, one of which being the

135 Three proteins (kappa-casein, timothy grass pollen extract, polyclonal a

136 They exhibited high hydrolytic activity on kappa-caseins, cleaving kappa-casein at four main sites,

137 differences were found in both the heavy and kappa chain repertoires between OmniRats and humans incl

138 ed significant differences in immunoglobulin kappa-chain V-II levels in KC patients compared to contr

139 The kappa coefficient among the chest radiologists was 0.663

140 Cohen's kappa coefficient for OS and NPS was 0.244, which is ind

141 t between the six observers was fair, with a kappa coefficient of 0.65 for the experienced graders an

142 The automatic grading method obtained a kappa coefficient of 0.72, which is a substantial agreem

143 Cohen kappa coefficient suggested substantial agreement in bot

144 A was 68.0% (95% CI, 53.3 to 80.5%), and the kappa coefficient was 0.68 (95% CI, 0.54 to 0.82).

145 rdxA correlated with phenotypic resistance (kappa coefficient, 0.76; 95% CI, 0.56 to 0.96).

146 23S rRNA (A2142G/A2143G) for clarithromycin (kappa coefficient, 0.84; 95% confidence interval [CI], 0

147 /N87K/D91Y/D91N/D91G/D99N) for levofloxacin (kappa coefficient, 0.90; 95% CI, 0.77 to 1.0).

148 r variability was determined using the Cohen kappa coefficient, and quantitative differences between

149 Appropriate statistical analyses (Cohen kappa coefficient, Mann-Whitney U test, t tests, and int

150 egative percent agreement (NPA), and Cohen's kappa coefficient.

151 erobserver agreement was measured with Cohen kappa coefficient.

152 notyping methods was evaluated using Cohen's kappa coefficient.

153 The Cohen kappa-coefficient was used to assess the concordance bet

154 kappa coefficients among the chest radiologists and the

155 We calculated the linear weighted kappa coefficients for inter- and intra-observer agreeme

156 eement was evaluated by calculating weighted kappa coefficients.

157 to field effect transistors (FET) with high-kappa dielectric gates, van der Waals heterostructures,

158 IFN-kappa expression has been implicated in the pathogenesis

159 , inhibition of ERK1/2 kinases activates IFN-kappa expression.

160 Cohen kappa for interrater agreement was 0.938.

161 ually possess specific thermal conductivity (kappa), forming a digital set of kappa values.

162 led abundance of boron isotopes and measured kappa greater than 1600 watts per meter-kelvin at room t

163 e (intraclass correlation coefficient, >0.8; kappa > 0.6) underwent univariable analysis.

164 greement was substantial for most diagnoses (kappa > 0.61) with percent agreements ranging from 66% t

165 uencing for K65R, K103NS, M184VI, and G190A (kappa > 0.85) and substantial agreement for Y181C (kappa

166 egeneration (AMD) showed moderate agreement (kappa >= 0.34).

167 ial agreement for glaucoma/glaucoma suspect (kappa >= 0.52) compared with an FTF examination.

168 Interpretations agreed for >=77% of images (kappa >= 0.52) taken at a similar time on a different da

169 ct (kappa >= 0.71) and diabetic retinopathy (kappa >= 0.61) and moderate to substantial agreement for

170 Interpretations agreed for >=81% of images (kappa >= 0.61) taken over the course of a morning; compl

171 0.83) and interobserver agreement was >=93% (kappa >= 0.66); complete disagreement did not occur.

172 s showed substantial agreement for cataract (kappa >= 0.71) and diabetic retinopathy (kappa >= 0.61)

173 graphic features agreed for >=88% of images (kappa >= 0.75) taken within minutes on the same day; com

174 Intraobserver agreement was >=93% (kappa >= 0.83) and interobserver agreement was >=93% (ka

175 ion factors <kappa(2)> = 0.17 +/- 0.16 and <|kappa|> = 0.35 +/- 0.20, contextualized within a static

176 viduals with no significant difference in Ig kappa/Ig lambda ratios or heavy chain levels.

177 nces of both the Ig heavy-chain (IgH) and Ig kappa (IgK) loci with the human IgK germline variable se

178 da-carrageenan) and the gametophytes (mainly kappa/iota-carrageenans).

179 on, we found that the isotope enhancement of kappa is considerably lower for boron phosphide and boro

180 In contrast, IFN-kappa is constitutively expressed in uninfected keratino

181 on signal-binding protein for immunoglobulin kappa J region (RBPJkappa).

182 lity analysis was performed using the Fleiss kappa (kappa) statistic to determine consistency among r

183 Kappa (kappa) statistics were applied to determine the d

184 e value (NPV), sensitivity, specificity, and kappa (kappa) statistics were generated for each diagnos

185 tasets (site 1 FFDM: linearly weighted Cohen kappa [kappa(w)] = 0.75 [95% CI: 0.74, 0.76]; site 1 SM:

186 who showed consistency but with variability (kappa [kappa]=0.79).

187 achieved overall accuracies of 92% (Cohen's kappa, kappa = 0.89) and 86% (kappa = 0.78) in the ex vi

188 se optical phonons significantly reduces the kappa(L) and enhances the thermoelectric performance in

189 oupling results in an intrinsically ultralow kappa(L) value in the all-inorganic layered RP perovskit

190 We have measured the anisotropic kappa(L) value of the Cs(2)PbI(2)Cl(2) single crystal an

191 l(2) single crystal and observed an ultralow kappa(L) value of ~0.37-0.28 W/mK in the temperature ran

192 cally ultralow lattice thermal conductivity (kappa(L)) in the single crystal of all-inorganic layered

193 show ultralow lattice thermal conductivity (kappa(L)) of 0.74-0.47 W/mK in the 300-723 K range and h

194 f selective T-cell lymphopenia with inverted kappa/lambda ratio in several kindreds.

195 uimolar SnSe and SnS in the GeTe reduces the kappa(latt) by effective phonon scattering because of th

196 erein, we have demonstrated the reduction of kappa(latt) of (GeTe)(1-2x)(SnSe)(x)(SnS)(x) very near t

197 )(SnSe)(0.025)(SnS)(0.025) exhibits ultralow kappa(latt) of ~0.30 W/mK at 300 K.

198 icantly higher lattice thermal conductivity (kappa(latt)) compared to that of its theoretical minimum

199 receptor-type tyrosine-protein phosphatases kappa led to acquisition of a full mesenchymal, rather t

200 We characterized the heavy chain and kappa light chain antibody repertoires of a model animal

201 scFv construct and of Protein L, a human IgG kappa light chain binding protein.

202 vering the full rat heavy chain variable and kappa light chain variable regions repertoire for the ge

203 ted with proteinuria composed mainly of free kappa light chains.

204 tional in vitro testing of nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-kap

205 H. pylori-induced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kapp

206 H2-terminal kinase (JNK), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kapp

207 1 (TNFR1) activation controls nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kapp

208 p65 translocation, a subunit nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB),

209 inhibition robustly enhances nuclear factor kappa-light-chain-enhancer of activated B cells activity

210 parthenolide, a caspase-1 and nuclear factor kappa-light-chain-enhancer of activated B cells inhibito

211 SOD2 acetylation, NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells) activit

212 the cell undergoes NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells)-depende

213 human LC gene into the mouse immunoglobulin kappa locus, ensuring its production by all plasma cells

214 Existing low-kappa materials (such as silicon oxide derivatives, orga

215 compared to that of its theoretical minimum (kappa(min)) of ~0.3 W/mK.

216 eTe)(1-2x)(SnSe)(x)(SnS)(x) very near to its kappa(min).

217 atological exploration found an indolent IgG-kappa multiple myeloma.

218 phenoxo-phosphonate Ru complex [Ru(III)(tPaO-kappa-N(2)O(P)O(C))(py)(2)](2-), 4(2-), where tPaO(5-) i

219 dine (py) of general formula [Ru(II)(H(3)tPa-kappa-N(3)O)(py)(2)](+), 2(+), has been prepared and tho

220 verall interreader agreement showed a Fleiss kappa of 0.61 (95% confidence interval, 0.53-0.70).

221 We describe a Kappa-on-Heavy (KoH) mouse that produces a class of high

222 The kappa opioid receptor (kappaOR) is an important target f

223 ent work has established a role for both the Kappa Opioid Receptor (KOR) and its endogenous ligand dy

224 otypical member of the receptor-inactivating kappa opioid receptor (KOR) antagonists, norbinaltorphim

225 We evaluated the occupancy of the kappa opioid receptor (KOR) by naltrexone measured with

226 Despite a growing interest in the kappa opioid receptor (KOR), KOR-selective fluorescent p

227 It is well known that activation of the kappa opioid receptor system modulates negative affect a

228 macology of full and partial agonists at the kappa opioid receptor.

229 and efficacy-delimited conformations of the kappa opioid receptor.

230 phoria, but recent studies now implicate the kappa opioid system in the modulation of negative affect

231 ence of hallucinogen studies, the effects of kappa-opioid agonists on human brain function are not we

232 ast-fail approach evaluated the potential of kappa-opioid receptor (KOR) antagonism for treating anhe

233 orted anhedonia, 8 weeks of treatment with a kappa-opioid receptor (KOR) antagonist resulted in signi

234 Salvinorin A (SA) is a kappa-opioid receptor agonist and atypical dissociative

235 minescent assay, the efficacy and potency of kappa opioids was determined.

236 n-1-ylcyclohexyl]acetamide (U50,488) for the kappa OR (KOR).

237 press either immunoglobulin (Ig) light chain kappa or lambda, we designed a second-generation CAR tar

238 filtrating immune cells, but with interferon-kappa production by keratinocytes.

239 r Protein tyrosine phosphatase receptor-type kappa (PTPRK), as a Wnt inhibitor in human cancer cells

240 neural network model was quadratic weighted kappa (QWK) comparing the agreement of the machine-read

241 t perfect concordance between the 2 tracers (kappa ranged from 0.871 to 1).

242 modest binding affinity for mu-, delta-, and kappa-receptors were synthesized.

243 Percent agreement, kappa, sensitivity, and specificity were calculated for

244 Content Validity Index (I-CVI) and modified Kappa statistic (K*), confirmed the content validity of

245 est was used for difference analysis and the kappa statistic for consistency analysis.

246 e calculated the percent concordance and the kappa statistic for paired-specimen results, and determi

247 tween LFA and GM-EIA was 89.0%, generating a Kappa statistic of 0.698, representing good agreement, w

248 A and Bio-Rad GM-EIA was 94.7%, generating a kappa statistic of 0.820.

249 Kappa statistic was 0.74 (95% CI; 0.58 to 0.89); 0.64 an

250 The kappa statistic was used to compare ratings between exam

251 m's outcomes, VIA image agreement rates, and Kappa statistic were compared before, during, and after

252 l reading of the MRDTI images was excellent (kappa statistic, 0.91).

253 -consult appropriateness was assessed by the kappa statistic.

254 alysis was performed using the Fleiss kappa (kappa) statistic to determine consistency among raters.

255 asked observer was assessed (percentage, and kappa-statistic with 95% confidence interval) for images

256 y of the two radiologists was evaluated with kappa statistical analysis, and the difference between E

257 a paired t test for continuous endpoints or Kappa statistics for categorical endpoints.

258 by calculating percentages of agreement and kappa statistics for duplicate gradings of baseline colo

259 2), Student t test, logistic regression, and kappa statistics were applied.

260 der agreement, as assessed by pairwise Cohen kappa statistics, varied as a function of feature and im

261 criterion level was assessed by using Cohen kappa statistics.

262 Interobserver reliability was assessed with kappa statistics.

263 Kappa (kappa) statistics were applied to determine the degree o

264 (NPV), sensitivity, specificity, and kappa (kappa) statistics were generated for each diagnosis.

265 r agreement was assessed by using the Fleiss kappa test.

266 Cohen kappa value comparing the consensus rating of ResNet-50

267 of cardiovascular disease risk category, the kappa value for all test CT scans was 0.90 (95% confiden

268 interval [CI]: 0.45, 0.47), with the highest kappa value for CO-RADS categories 1 (0.58, 95% CI: 0.54

269 e case of reader 2, OCT actually reduced the kappa value from moderate agreement to agreement equal t

270 ance to 4 ophthalmologists, showing a higher kappa value of 0.471 (95% CI, 0.330-0.606) versus a rang

271 5% confidence interval [CI], 0.927-0.950), a kappa value of 0.718 (95% CI, 0.685-0.751), and accuracy

272 ance to 4 ophthalmologists, showing a higher kappa value of 0.789 (95% CI, 0.675-0.875) versus a rang

273 ody assays was 98.7% (658/667), with Cohen's kappa value of 0.919 (95% confidence interval [CI], 0.86

274 Fleiss kappa value was 0.47 (95% confidence interval [CI]: 0.45

275 Fleiss kappa value was calculated, and scores of individual obs

276 Concordance (Cohen Kappa value) between the 2 data sources varied from 0.79

277 le override, haptic orientation, large-angle kappa value, and high hyperopia.

278 kappa-value of 0.128 and 0.198 between PERCIST and imPER

279 cordance between CT- and PET-based criteria (kappa-value of 0.346 and 0.355 between PERCIST and imPER

280 kappa values across all Lung-RADS classifications were g

281 robserver agreement was almost perfect, with kappa values between 0.88 and 0.92.

282 Kappa values for agreement between endoscopists ranged f

283 lume) TAC scoring and with linearly weighted kappa values for cardiovascular risk categories (Agatsto

284 atives, organic compounds and aerogels) have kappa values greater than 2 and poor thermo-mechanical p

285 rdance between these 3 systems was moderate (kappa values NSQIP-NHSN = 0.50 [0.40-0.60], administrati

286 to substantial, with mean linearly weighted kappa values of 0.60 +/- 0.01 for CO-RADS scores and 0.5

287 amorphous boron nitride films with ultralow kappa values of 1.78 and 1.16 (close to that of air, kap

288 ed significantly higher sensitivity, AUC and Kappa values than radiography.

289 must have low relative dielectric constants (kappa values), serve as diffusion barriers against the m

290 g characteristic analysis, linearly weighted kappa values, and classification accuracy.

291 Percent agreement, kappa values, sensitivity, and specificity were calculat

292 nductivity (kappa), forming a digital set of kappa values.

293 es with an antigen binding site made up of 2 kappa variable domains.

294 anging from 0.02 to 0.6; three-reader Fleiss kappa varied from -0.17 to 0.56.

295 (w)] = 0.75 [95% CI: 0.74, 0.76]; site 1 SM: kappa(w) = 0.71 [95% CI: 0.64, 0.78]; site 2 SM: kappa(w

296 a(w) = 0.71 [95% CI: 0.64, 0.78]; site 2 SM: kappa(w) = 0.72 [95% CI: 0.70, 0.75]).

297 (site 1 FFDM: linearly weighted Cohen kappa [kappa(w)] = 0.75 [95% CI: 0.74, 0.76]; site 1 SM: kappa(

298 Kappa was used to show agreement between phenotypes.

299 intraclass correlation coefficient and Cohen kappa) was followed by nonparametric (Kruskal-Wallis ana

300 alysis, and interrater agreement using Light kappa were determined.